
Aurora Cannabis ACB
$ 4.35
3.08%
Annual report 2025
added 01-03-2026
Aurora Cannabis Historical Prices 2011-2026 | ACB
Annual Historical Prices Aurora Cannabis
| 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 4.08 | 4.62 | 0.51 | 0.51 | 5.41 | 8.31 | 25.9 | 59.5 | 91.6 | 20.6 | 5.03 | 10.9 | - | - | - |
All numbers in CAD currency
Indicator range from annual reports
| Maximum | Minimum | Average |
|---|---|---|
| 91.6 | 0.51 | 19.8 |
Historical Prices of other stocks in the Drug manufacturers industry
| Issuer | Historical Prices | Price | % 24h | Market Cap | Country | |
|---|---|---|---|---|---|---|
|
Zynerba Pharmaceuticals
ZYNE
|
0.44 | - | - | $ 55.5 M | ||
|
Alimera Sciences
ALIM
|
3.97 | - | - | $ 142 M | ||
|
Adamis Pharmaceuticals Corporation
ADMP
|
0.12 | - | 0.86 % | $ 117 M | ||
|
Aerie Pharmaceuticals
AERI
|
7.02 | - | - | $ 754 M | ||
|
Canopy Growth Corporation
CGC
|
1.32 | $ 1.19 | 4.74 % | $ 128 M | ||
|
AcelRx Pharmaceuticals
ACRX
|
0.86 | - | 7.5 % | $ 6.35 M | ||
|
Cronos Group
CRON
|
3.69 | $ 2.69 | 2.09 % | $ 1.41 B | ||
|
Agile Therapeutics
AGRX
|
0.6 | - | 10.11 % | $ 58.2 M | ||
|
Catalent
CTLT
|
60 | - | - | $ 11.5 B | ||
|
DURECT Corporation
DRRX
|
1.21 | - | - | $ 50.1 M | ||
|
Eagle Pharmaceuticals
EGRX
|
26.3 | - | -39.89 % | $ 27.7 M | ||
|
Endo International plc
ENDP
|
0.29 | - | - | $ 28.9 M | ||
|
Calliditas Therapeutics AB (publ)
CALT
|
19.7 | - | -0.1 % | $ 2.03 B | ||
|
Evoke Pharma
EVOK
|
0.67 | - | - | $ 36.6 M | ||
|
HEXO Corp.
HEXO
|
0.71 | - | 2.45 % | $ 38.1 M | ||
|
Emergent BioSolutions
EBS
|
2.71 | $ 12.43 | 0.61 % | $ 636 M | ||
|
Athenex
ATNX
|
1.75 | - | -23.39 % | $ 1.76 M | ||
|
Avadel Pharmaceuticals plc
AVDL
|
7.54 | $ 21.51 | -0.21 % | $ 2.05 B | ||
|
Evolus
EOLS
|
14.3 | $ 6.7 | 0.68 % | $ 416 M | ||
|
Harrow Health
HROW
|
10.7 | $ 49.11 | 0.22 % | $ 1.6 B | ||
|
Jupiter Wellness
JUPW
|
1.52 | - | - | $ 33.6 M | ||
|
China Pharma Holdings
CPHI
|
0.26 | $ 1.2 | -0.83 % | $ 21 M | ||
|
cbdMD
YCBD
|
0.39 | $ 1.17 | -13.31 % | $ 5.05 M | ||
|
OrganiGram Holdings
OGI
|
1.58 | $ 1.73 | 2.98 % | $ 402 M | ||
|
Bausch Health Companies
BHC
|
9.27 | $ 7.18 | 3.24 % | $ 2.62 B | ||
|
Lannett Company
LCI
|
0.57 | - | 1.15 % | $ 7.11 M | ||
|
Neoleukin Therapeutics
NLTX
|
3.49 | - | - | $ 193 M | ||
|
Cumberland Pharmaceuticals
CPIX
|
6.3 | $ 4.01 | 0.88 % | $ 56.4 M | ||
|
Sundial Growers
SNDL
|
1.45 | $ 1.74 | 4.82 % | $ 3.37 M | ||
|
Organogenesis Holdings
ORGO
|
3.15 | $ 4.71 | -9.17 % | $ 620 M | ||
|
Pacira BioSciences
PCRX
|
25.5 | $ 24.43 | -5.6 % | $ 1.13 B | ||
|
Rockwell Medical
RMTI
|
1.52 | $ 0.88 | 5.11 % | $ 20.5 M | ||
|
PetIQ
PETQ
|
13.6 | - | 1.64 % | $ 400 M | ||
|
Perrigo Company plc
PRGO
|
28.8 | $ 13.96 | 0.29 % | $ 1.92 B | ||
|
ProPhase Labs
PRPH
|
8.24 | $ 0.32 | -27.93 % | $ 5.07 M | ||
|
Radius Health
RDUS
|
8.32 | - | - | $ 1.42 B | ||
|
Recro Pharma
REPH
|
1.4 | - | -4.76 % | $ 65.3 M | ||
|
Relmada Therapeutics
RLMD
|
5.37 | $ 4.36 | -9.73 % | $ 131 M | ||
|
OptiNose
OPTN
|
1.71 | - | - | $ 1.08 B | ||
|
Assertio Holdings
ASRT
|
0.93 | $ 9.18 | 1.21 % | $ 652 M | ||
|
PLx Pharma
PLXP
|
5.05 | - | -27.8 % | $ 2.56 M | ||
|
Solid Biosciences
SLDB
|
5.53 | $ 5.47 | -3.01 % | $ 223 M | ||
|
SCYNEXIS
SCYX
|
1.47 | $ 0.63 | 0.27 % | $ 30.1 M | ||
|
Sonoma Pharmaceuticals
SNOA
|
2.95 | $ 3.67 | 0.82 % | $ 4.55 M | ||
|
Tricida
TCDA
|
7.96 | - | - | $ 3.25 M | ||
|
Tilray
TLRY
|
1.93 | $ 9.85 | 9.08 % | $ 6.09 B | ||
|
TherapeuticsMD
TXMD
|
2.29 | $ 1.61 | -1.23 % | $ 16.8 M | ||
|
Zomedica Corp.
ZOM
|
0.14 | - | -0.21 % | $ 98 M | ||
|
Veru
VERU
|
0.8 | $ 2.28 | 6.54 % | $ 308 M |